Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Creagh

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjectsT Creagh, J L Ruckle, D T Tolbert, et al.
Transactions of the Association of American Physicians|January 1, 1983
Suppression of recurrent genital herpes with oral acyclovirS E Straus, M Seidlin, H E Takiff, et al.
The New England Journal of Medicine|April 21, 1983
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjectsY J Bryson, M Dillon, M Lovett, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 13, 2019
Morbidity associated with the immediate vertical rectus abdominus myocutaneous flap reconstruction after radical pelvic surgeryM J Proctor, D A Westwood, S Donahoe, et al.
The New England Journal of Medicine|June 14, 1984
Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovirS E Straus, H E Takiff, M Seidlin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groupsP S Rosenberg, M H Gail, L K Schrager, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjectsT Creagh, J L Ruckle, D T Tolbert, et al.
Transactions of the Association of American Physicians|January 1, 1983
Suppression of recurrent genital herpes with oral acyclovirS E Straus, M Seidlin, H E Takiff, et al.
The New England Journal of Medicine|April 21, 1983
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjectsY J Bryson, M Dillon, M Lovett, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 13, 2019
Morbidity associated with the immediate vertical rectus abdominus myocutaneous flap reconstruction after radical pelvic surgeryM J Proctor, D A Westwood, S Donahoe, et al.
The New England Journal of Medicine|June 14, 1984
Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovirS E Straus, H E Takiff, M Seidlin, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groupsP S Rosenberg, M H Gail, L K Schrager, et al.
Pageof 4